US Stock MarketDetailed Quotes

IONS Ionis Pharmaceuticals

Watchlist
  • 30.020
  • +0.280+0.94%
Trading Apr 29 15:03 ET
4.77BMarket Cap-9.88P/E (TTM)

About Ionis Pharmaceuticals Company

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Company Profile

SymbolIONS
Company NameIonis Pharmaceuticals
Listing DateApr 17, 1991
Issue Price57.56
Founded1989
CEODr. Brett P. Monia, PhD
MarketNASDAQ
Employees1069
Fiscal Year Ends12-31
Address2855 Gazelle Court
CityCarlsbad
ProvinceCalifornia
CountryUnited States of America
Zip Code92010
Phone1-760-931-9200

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Brett P. Monia, PhD
  • Chief Executive Officer and Director
  • 15.40M
  • Elizabeth L. Hougen
  • Executive Vice President, Finance, Principal Accounting Officer and Chief Financial Officer
  • 5.06M
  • Shannon L. Devers
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Patrick R. O'Neil, Esq.
  • Executive Vice President, Chief Legal Officer, General Counsel and Corporate Secretary
  • 3.43M
  • Kyle Jenne
  • Executive Vice President and Chief Global Product Strategy Officer
  • 4.30M
  • Joseph T. Baroldi
  • Executive Vice President and Chief Business Officer
  • --
  • Eugene Schneider
  • Executive Vice President and Chief Clinical Development and Operations Officer
  • --
  • Dr. Richard S. Geary,PhD
  • Executive Vice President and Chief Development Officer
  • 3.47M
  • Dr. C. Frank Bennett,PhD
  • Executive Vice President and Chief Scientific Officer
  • --
  • Eric E. Swayze, PhD
  • Executive Vice President, Research
  • --
  • Brian Birchler
  • Executive Vice President, Corporate and Development Operations
  • --
  • Dr. Joseph Loscalzo, M.D.,PhD
  • Chairman of the Board
  • 589.93K
  • B. Lynne Parshall, Esq.,J.D.
  • Director
  • 559.93K
  • Joan E. Herman
  • Independent Director
  • 561.93K
  • Allene M. Diaz
  • Independent Director
  • 551.93K
  • Michael J. Yang
  • Independent Director
  • 849.98K
  • Joseph Klein, III
  • Independent Director
  • 563.93K
  • Joseph H. Wender
  • Lead Independent Director
  • 619.93K
  • Dr. Spencer R. Berthelsen,M.D.
  • Independent Director
  • 569.93K
  • Dr. Michael Hayden, PhD
  • Independent Director
  • 549.93K

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.